7501 - 7550 of 9145 Results
Title
Year
-
OPENTitle: A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 329End Page: 332Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27259Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27259Citation Count: 20
-
OPENTitle: Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model ofParkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 77Issue #: 6Start Page: 930End Page: 941Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24375Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6235675Citation Count: 51
- Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson’s disease2024RESTRICTEDTitle: Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 11Start Page: 3702End Page: 3713Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awae303Citation Count: 25
-
OPENTitle: Structure–Functional–Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased LigandsJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 11Issue #: 3Start Page: 385End Page: 392Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.9b00575Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7074212Citation Count: 14
- The Kinase Fyn As a Novel Intermediate in l-DOPA-Induced Dyskinesia in Parkinson’s Disease2017OPENTitle: The Kinase Fyn As a Novel Intermediate in l-DOPA-Induced Dyskinesia in Parkinson’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 55Issue #: 6Start Page: 5125End Page: 5136Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12035-017-0748-3Citation Count: 25
- Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles2024OPENTitle: Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profilesJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.92775.3Best OA location URL: https://doi.org/10.7554/elife.92775.3Citation Count: 14
-
OPENTitle: Functional segregation of voltage-activated calcium channels in motoneurons of the dorsal motor nucleus of the vagusJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 114Issue #: 3Start Page: 1513End Page: 1520Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00432.2014Best OA location URL: http://doi.org/10.1152/jn.00432.2014Citation Count: 20
-
OPENTitle: The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein modelsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 15Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.049192Best OA location URL: https://journals.biologists.com/dmm/article-pdf/15/6/dmm049192/2145803/dmm049192.pdfCitation Count: 19
- The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study2015RESTRICTEDTitle: The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography studyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 4Start Page: 1736End Page: 1742Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.12.037Citation Count: 50
-
OPENTitle: Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect ofl‐DOPAtreatment and changes in levodopa‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 141Issue #: 4Start Page: 614End Page: 625Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.13997Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13997Citation Count: 44
-
OPENTitle: Unraveling the Biologic Basis for Domain-Specific Cognitive DeclineJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 25Issue #: 7Start Page: 741End Page: 743Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2017.04.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5870749Citation Count: 1
-
OPENTitle: Pure Autonomic Failure Versus Prodromal Dysautonomia in Parkinson's Disease: Insights from the BedsideJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 1Start Page: 141End Page: 144Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12360Citation Count: 13
-
OPENTitle: Epigenomic profile of GBA1 in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 140Issue #:Start Page: 108066End Page: 108066Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108066Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12825421/Citation Count: 1
-
OPENTitle: Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndromeJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 2Start Page: 1038End Page: 1049Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.13506Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13506Citation Count: 13
-
OPENTitle: Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteinsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 79Issue #:Start Page: 1End Page: 13Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.032Best OA location URL: https://doaj.org/article/93e67a90244e4782905f49cf680c102fCitation Count: 47
- The transition between turning and sitting in patients with Parkinson's disease: A wearable device detects an unexpected sequence of events2018RESTRICTEDTitle: The transition between turning and sitting in patients with Parkinson's disease: A wearable device detects an unexpected sequence of eventsJournal Name: Gait & PosturePublisher: Elsevier BVVol: 67Issue #:Start Page: 224End Page: 229Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.10.018Citation Count: 35
- Exosome/microvesicle content is altered in leucine‐rich repeat kinase 2 mutant induced pluripotent stem cell‐derived neural cells2019RESTRICTEDTitle: Exosome/microvesicle content is altered in leucine‐rich repeat kinase 2 mutant induced pluripotent stem cell‐derived neural cellsJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 528Issue #: 7Start Page: 1203End Page: 1215Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/cne.24819Citation Count: 16
- Valbenazine as treatment for Huntington's disease chorea2023RESTRICTEDTitle: Valbenazine as treatment for Huntington's disease choreaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 6Start Page: 459End Page: 460Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00163-1Citation Count: 5
-
OPENTitle: Mining the neuroimaging literatureJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.94909.2Citation Count: 0
- Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease2018RESTRICTEDTitle: Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 303Issue #:Start Page: 95End Page: 107Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.01.015Citation Count: 44
-
OPENTitle: Distinct AQP4 Alterations in Movement Disorders with Primary SynucleinopathyJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 12Start Page: 2804End Page: 2810Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70023Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70023Citation Count: 6
-
OPENTitle: α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)Journal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 73Issue #:Start Page: 229End Page: 243Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.007Best OA location URL: https://doaj.org/article/cf729f11ec754abb83db0191be6da9cfCitation Count: 45
-
OPENTitle: Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's diseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 480Issue #: 1Start Page: 78End Page: 82Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2010.06.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2943649Citation Count: 219
- Associating white matter microstructural integrity and improvements in reactive stepping in people with Parkinson’s Disease2024RESTRICTEDTitle: Associating white matter microstructural integrity and improvements in reactive stepping in people with Parkinson’s DiseaseJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 18Issue #: 4Start Page: 852End Page: 862Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11682-024-00867-wCitation Count: 4
-
OPENTitle: Closing the structure-to-function gap for LRRK2Journal Name: Trends in Biochemical SciencesPublisher: Elsevier BVVol: 47Issue #: 3Start Page: 187End Page: 188Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.tibs.2021.10.003Best OA location URL: http://www.cell.com/article/S0968000421002243/pdfCitation Count: 9
- Increased peripheral inflammation in asymptomatic leucine‐rich repeat kinase 2 mutation carriers2016RESTRICTEDTitle: Increased peripheral inflammation in asymptomatic leucine‐rich repeat kinase 2 mutation carriersJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 6Start Page: 889End Page: 897Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26529Citation Count: 98
-
OPENTitle: Lack of Cerebrospinal Fluid α‐Synuclein Seeding in VPS35 D620N ‐ and LRRK2 Y1699C ‐Linked Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 6Start Page: 1605End Page: 1608Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.70291Best OA location URL: https://doi.org/10.1002/mds.70291Citation Count: 0
-
OPENTitle: Hippocampal-striatal interaction in Parkinson’s disease with mild cognitive impairmentJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 14Issue #:Start Page: 100443End Page: 100443Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2026.100443Best OA location URL: https://doi.org/10.1016/j.prdoa.2026.100443Citation Count: 0
- Chronic Pain in Parkinson’s Disease: Prevalence, Sex Differences, Regional Anatomy and Comorbidities2025OPENTitle: Chronic Pain in Parkinson’s Disease: Prevalence, Sex Differences, Regional Anatomy and ComorbiditiesJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 12Issue #: 12Start Page: 2422End Page: 2432Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.70174Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.70174Citation Count: 5
- Gpnmb defines a phagocytic state of microglia linked to cell death in prion disease mouse model2026OPENTitle: Gpnmb defines a phagocytic state of microglia linked to cell death in prion disease mouse modelJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-026-73003-5Best OA location URL: https://doi.org/10.1038/s41467-026-73003-5Citation Count: 0
- DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI study2020RESTRICTEDTitle: DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 36End Page: 42Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.019Citation Count: 14
-
OPENTitle: STEP61is a substrate of the E3 ligase parkin and is upregulated in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 112Issue #: 4Start Page: 1202End Page: 1207Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1417423112Best OA location URL: https://www.pnas.org/content/pnas/112/4/1202.full.pdfCitation Count: 62
-
OPENTitle: Mining the neuroimaging literatureJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.94909Best OA location URL: https://elifesciences.org/reviewed-preprints/94909.pdfCitation Count: 1
-
OPENTitle: Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD CohortJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 286End Page: 303Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29288Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29288Citation Count: 49
- The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's Disease2018OPENTitle: The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 171End Page: 176Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.12591Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12591Citation Count: 67
- Protection from cyanide‐induced brain injury by the Nrf2 transcriptional activator carnosic acid2015OPENTitle: Protection from cyanide‐induced brain injury by the Nrf2 transcriptional activator carnosic acidJournal Name: Journal of NeurochemistryPublisher: WileyVol: 133Issue #: 6Start Page: 898End Page: 908Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.13074Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13074Citation Count: 63
- Melatonin for Huntington's Disease (HD) gene carriers with HD-related sleep disturbance - A pilot study2025RESTRICTEDTitle: Melatonin for Huntington's Disease (HD) gene carriers with HD-related sleep disturbance - A pilot studyJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 129Issue #:Start Page: 238End Page: 244Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2025.02.032Citation Count: 7
- Wearable sensors for assessing disease severity and progression in Progressive Supranuclear Palsy2023OPENTitle: Wearable sensors for assessing disease severity and progression in Progressive Supranuclear PalsyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 109Issue #:Start Page: 105345End Page: 105345Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105345Citation Count: 16
-
OPENTitle: Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT imagesJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 16Issue #:Start Page: 539End Page: 544Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2017.08.021Best OA location URL: https://doi.org/10.1016/j.nicl.2017.08.021Citation Count: 112
-
OPENTitle: Quantitative measures of total and phosphorylated alpha-synuclein in skin tissue as potential biomarkers for synucleinopathiesJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 16Issue #: 3Start Page: 438End Page: 451Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/1877718x261420669Best OA location URL: https://doi.org/10.1177/1877718x261420669Citation Count: 0
-
OPENTitle: Direct disassembly of α-syn preformed fibrils into α-syn monomers by an all-D-peptideJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 271End Page: 271Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01132-7Best OA location URL: https://www.nature.com/articles/s41531-025-01132-7.pdfCitation Count: 2
-
OPENTitle: Reconstitution of cargo-induced LC3 lipidation in mammalian selective autophagyJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 7Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1126/sciadv.abg4922Best OA location URL: https://doi.org/10.1126/sciadv.abg4922Citation Count: 55
- Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s Disease2019OPENTitle: Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s DiseaseJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 18Issue #: 5Start Page: 2109End Page: 2120Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00982Citation Count: 75
- Deep brain stimulation of the ventromedial prefrontal cortex causes reorganization of neuronal processes and vasculature2015RESTRICTEDTitle: Deep brain stimulation of the ventromedial prefrontal cortex causes reorganization of neuronal processes and vasculatureJournal Name: NeuroImagePublisher: Elsevier BVVol: 125Issue #:Start Page: 422End Page: 427Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2015.10.049Citation Count: 52
-
OPENTitle: Cholinergic activity and levodopa‐induced dyskinesia: a multitracer molecular imaging studyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 9Start Page: 632End Page: 639Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.438Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.438Citation Count: 19
-
OPENTitle: Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 363Issue #:Start Page: 114370End Page: 114370Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2023.114370Best OA location URL: https://doi.org/10.1016/j.expneurol.2023.114370Citation Count: 15
- Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?2022RESTRICTEDTitle: Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1346End Page: 1359Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29058Citation Count: 20
-
OPENTitle: The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 32Issue #: 6Start Page: 710End Page: 720Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2023.12.024Best OA location URL: https://doi.org/10.1016/j.jagp.2023.12.024Citation Count: 10
- Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)2018RESTRICTEDTitle: Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)Journal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 1Start Page: 67End Page: 77Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27492Citation Count: 205
-
OPENTitle: Leucine-rich repeat kinase 2 at a glanceJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 136Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/jcs.259724Best OA location URL: https://journals.biologists.com/jcs/article-pdf/136/17/jcs259724/3144584/jcs259724.pdfCitation Count: 19